Search for Jean-Pierre Garnier and
    1. July 6, 2012

      GSK ills symptomatic of wider malaise

      More than a year after Andrew Witty was selected to run GlaxoSmithKline, the executive director of marketing for its biggest...

    2. May 11, 2012

      Witty targets HGS with first hostile bid

      Henry Wellcome, the US immigrant who laid the foundations 130 years ago for the UK-based pharmaceutical group...

    1. October 20, 2011

      Actelion shares tumble over quarterly results

      Actelion, Europe’s biggest biotechnology group by sales, saw its shares fall sharply on Thursday as third-quarter results...

    2. May 5, 2011

      Actelion fends off Elliott Advisors

      Rebel shareholders’ efforts to overturn the incumbent management of Actelion at the annual general meeting of the Swiss...

    3. May 4, 2011

      Garnier defends Actelion against rebels

      Jean-Pierre Garnier, the senior pharmaceutical executive up for election on Thursday as chairman of Actelion, has launched a...

    4. April 14, 2011

      Elliott keeps up pressure on Actelion

      Rebel investors stepped up their criticism of Actelion on Thursday as they pursued efforts to appoint new board members to...

    5. FT Alphaville

      April 6, 2011

      Snap news

      Breaking pre-market news on Wednesday, - Commerzbank to raise €11bn via mandatory convertible notes and rights issue –...

    6. April 6, 2011

      Actelion chooses Garnier as next chairman

      Actelion has beefed up its defences in its battle with US activist investor Elliott Advisors with the surprise nomination of...

    7. December 14, 2009

      The careerist: Replacing a hero: how to succeed the boss from heaven

      Any promotion forces you to redouble your efforts to impress, and this is especially true when your predecessor was...

    8. December 13, 2009

      The careerist: Replacing a hero

      Any promotion forces you to redouble your efforts to impress, and this is especially true when your predecessor was...

    9. December 1, 2009

      DIC's business grandees

      With the Dubai brand hit hard by last week's events, investment group Dubai International Capital's chairman Sameer Al...

    10. November 3, 2009

      Shire hires GSK contender

      As GlaxoSmithKline boss Andrew Witty celebrates his second anniversary at the helm of the pharma group, one of his former...

    11. May 21, 2009

      Dogged in pursuit of the fat-cats

      When the cultivated Scottish voice of Guy Jubb meted out his objections to the pay report at the Shell meeting in The Hague...

    12. May 21, 2009

      Glaxo patient under monitoring

      Avoiding undue pressure on the pulse-point over pay, GlaxoSmithKline chairman Sir Christopher Gent and pay committee boss...

    13. May 20, 2009

      Investors take aim after Shell takes them for granted

      John Kerr wasn't offered a final cigarette, but there was a moment yesterday when the former diplomat, chainsmoker and...

    14. May 19, 2009

      Investors take aim after Shell takes them for granted

      John Kerr wasn’t offered a final cigarette, but there was a moment on Tuesday when the former diplomat, chainsmoker and...

    15. May 11, 2009

      GSK investors urged to reject Garnier package

      A leading investor watchdog has called on shareholders to reject a performance-related share package for Jean-Pierre...

    16. May 10, 2009

      GSK investors urged to reject Garnier package

      A leading investor watchdog has called on shareholders to reject a performance-related share package for Jean-Pierre...

    17. February 16, 2009

      A holistic approach to leadership

      He speaks with a hint of the accent of his native Germany, mixed with the twang of the English of Canada where he grew up....

    18. February 15, 2009

      A holistic approach

      He speaks with a hint of the accent of his native Germany, mixed with the twang of the English of Canada where he grew up....

    19. February 2, 2009

      An acute talent for innovation

      Sir James Black places his walking stick on one side, eases himself into a plump yellow sofa at the Royal Society of...

    20. February 1, 2009

      An acute talent for innovation

      Sir James Black places his walking stick on one side, eases himself into a plump yellow sofa at the Royal Society of...

    21. October 21, 2008

      As supply of execs rises, price must fall

      From Mr George Collie. Sir, Parts of your report on corporate incentives (“Shareholders and boards in bonus face-off”,...

    22. October 7, 2008

      Dose of change for a struggling sector

      The decision by the board of Sanofi-Aventis of France last month to oust its chief executive and replace him with not only...

    23. October 6, 2008

      Medicine for a sector

      The decision by the board of Sanofi-Aventis of France last month to oust its chief executive and replace him with not only...

    24. September 10, 2008

      GSK's Viehbacher to join Sanofi-Aventis

      Chris Viehbacher, head of GlaxoSmithKline's North American pharmaceutical operations, is poised to join Sanofi-Aventis as a...

    25. September 9, 2008

      GSK executive quits to lead rival

      Chris Viehbacher, one of the most senior executives at GlaxoSmithKline, the pharmaceuticals group, is to quit for a top job...

    26. September 9, 2008

      Bonus of contention

      GlaxoSmithKline endured shareholder discontent to push through a "retention bonus" for Chris Viehbacher, a loser in the...

    27. September 9, 2008

      GSK executive's exit heralds drug sector shake-up

      Chris Viehbacher, one of the most senior executives at GlaxoSmithKline, the UK pharmaceuticals group, is to quit for a top...

    28. September 9, 2008

      GSK executive quits to lead rival

      Chris Viehbacher, one of the most senior executives at GlaxoSmithKline, the pharmaceuticals group, is to quit for a top job...

    29. August 29, 2008

      JPG returns to his French roots

      After suffering Napoleonic jibes during his time, Jean-Pierre Garnier , the former head of GlaxoSmithKline, the UK-based...

    30. July 24, 2008

      FTSE 100 CEOs

      Andrew Witty, the 43-year-old who yesterday made his first results presentation as the new boss of GSK, makes for a rather...

    31. July 23, 2008

      FTSE100 CEOs

      Andrew Witty, the 43-year-old who on Wednesday made his first results presentation as the new boss of GSK, makes for a...

    32. May 24, 2008

      The Week

      Shareholders are revolting - as company directors are learning to their cost, or at least embarrassment. As the Bank of...

    33. May 22, 2008

      JP Garnier takes his medicine

      Glasses perched on the edge of his nose, Jean-Pierre Garnier was quietly forceful in defence of the strategy of the drugs...

    34. May 21, 2008

      GSK faces revolt over retention bonus

      GlaxoSmithKline has become the latest company to face a shareholder revolt over bonus payments to retain an executive in a...

    35. May 19, 2008

      GSK chief leaves a mixed prognosis

      Jean-Pierre Garnier, the first chief executive of GlaxoSmithKline, the UK-based pharmaceuticals company created through a...

    36. May 17, 2008

      Hikma threatens to move domicile if tax rules change

      The chief executive of Hikma, the UK-quoted generic medicines company, yesterday joined ranks with other groups that have...

    37. May 16, 2008

      Tough US drugs bar to remain,says GSK

      US regulators have permanently raised the bar for approving new medicines in a way that will force companies to change how...

    38. May 15, 2008

      GSK sees tough US regulation

      US regulators have permanently raised the bar for approving new medicines in a way that will force companies to change how...

    Search for Jean-Pierre Garnier and